ANA ZAPATA GONZALEZ: Open Payments
NPI 1497401400 · RADCLIFF, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$949 in 21 payments from 12 companies in 2025. Trend: 2023 $103 · 2024 $363 · 2025 $949
Food & beverage: $949
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $310 |
| AstraZeneca Pharmaceuticals LP | 3 | $164 |
| GlaxoSmithKline, LLC. | 1 | $122 |
| Novo Nordisk Inc | 2 | $91 |
| SI-BONE, INC. | 1 | $69 |
| Lilly USA, LLC | 3 | $56 |
| Astellas Pharma US Inc | 3 | $45 |
| Paratek Pharmaceuticals, Inc. | 1 | $30 |
| Eisai Inc. | 1 | $18 |
| Exact Sciences Corporation | 1 | $17 |
Products named: QULIPTA, AIRSUPRA, SHINGRIX, UBRELVY, Ozempic, JARDIANCE, Veozah, NUZYRA.
Industry payments across KY — which companies pay providers there.
